Photocure ASA PHCUF:Grey Market

RT Quote | Exchange | USD
Last | 02/16/21 EST
13.50UNCH (UNCH)
Volume
300
52 week range
6.80 - 13.50

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close13.50
  • 52 Week High13.50
  • 52 Week High Date02/16/21
  • 52 Week Low6.80
  • 52 Week Low Date04/30/20
  • Market Cap361.9M
  • Shares Out26.61M
  • 10 Day Average Volume157
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change28.57

RATIOS/PROFITABILITY

  • EPS (TTM)0.06
  • P/E (TTM)231.86
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Photocure ASA News

There is no recent news for this security.

Latest PHCUF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Photocure ASA is a Norway-based company active in the pharmaceutical industry. It operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection...
Jan Egberts M.D.
Chairman
Daniel Schneider
President
Erik Dahl
Chief Financial Officer
Grete Hogstad
Vice President
Susanne Strauss
Vice President
Address
Hoffsveien 4
Oslo
0275
Norway